This report is built to visualize quantitative market trends within Orthopedic Devices therapeutic area.
Conditions for spontaneous bone healing after trauma or orthopedic surgery are not always ideal. Even with the efficacy of modern internal fixation and spinal fusion techniques, factors such as poor vascularity, malnutrition, and substantial bone or soft tissue loss can impede effective bone growth. As a result, the market for Bone Grafts and Substitutes has emerged and exploded.
Autograft bone is considered the gold-standard treatment; however, the amount of autograft bone available is often insufficient, and the graft harvesting procedure presents a number of comorbidities including donor site pain and infection. Due to these drawbacks, a soaring demand for alternatives to autograft bone has arisen globally.
An array of Bone Grafts and Substitutes are currently available-Allograft Bone, Bone Morphogenetic Proteins (BMPs), Demineralized Bone Matrices (DBMs), Synthetic Bone Substitutes, and Cell-based Matrices.
Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
- DePuy Synthes
- Zimmer Biomet
For more information about this report visit here.